AC Immune Statistics

Total Valuation

AC Immune has a market cap or net worth of $300.58 million. The enterprise value is $172.18 million.

Market Cap	300.58M
Enterprise Value	172.18M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026, before market open.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

AC Immune has 99.20 million shares outstanding. The number of shares has increased by 1.06% in one year.

Current Share Class	99.20M
Shares Outstanding	99.20M
Shares Change (YoY)	+1.06%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	5.88%
Owned by Institutions (%)	6.18%
Float	38.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	62.52
Forward PS	7.66
PB Ratio	5.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	38.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.10.

Current Ratio	1.02
Quick Ratio	0.97
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-360.54

Financial Efficiency

Return on equity (ROE) is -89.65% and return on invested capital (ROIC) is -51.51%.

Return on Equity (ROE)	-89.65%
Return on Assets (ROA)	-22.35%
Return on Invested Capital (ROIC)	-51.51%
Return on Capital Employed (ROCE)	-115.62%
Weighted Average Cost of Capital (WACC)	13.02%
Revenue Per Employee	$36,934
Profits Per Employee	-$728,210
Employee Count	122
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.15% in the last 52 weeks. The beta is 1.63, so AC Immune's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	+84.15%
50-Day Moving Average	2.92
200-Day Moving Average	2.89
Relative Strength Index (RSI)	51.20
Average Volume (20 Days)	263,209

Short Selling Information

The latest short interest is 2.96 million, so 6.01% of the outstanding shares have been sold short.

Short Interest	2.96M
Short Previous Month	3.09M
Short % of Shares Out	6.01%
Short % of Float	n/a
Short Ratio (days to cover)	11.85

Income Statement

In the last 12 months, AC Immune had revenue of $4.51 million and -$88.84 million in losses. Loss per share was -$0.88.

Revenue	4.51M
Gross Profit	-66.67M
Operating Income	-86.84M
Pretax Income	-88.84M
Net Income	-88.84M
EBITDA	-85.09M
EBIT	-86.84M
Loss Per Share	-$0.88

Full Income Statement

Balance Sheet

The company has $115.28 million in cash and $5.73 million in debt, giving a net cash position of $109.55 million or $1.10 per share.

Cash & Cash Equivalents	115.28M
Total Debt	5.73M
Net Cash	109.55M
Net Cash Per Share	$1.10
Equity (Book Value)	56.60M
Book Value Per Share	0.56
Working Capital	2.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$87.35 million and capital expenditures -$1.14 million, giving a free cash flow of -$88.88 million.

Operating Cash Flow	-87.35M
Capital Expenditures	-1.14M
Depreciation & Amortization	1.76M
Net Borrowing	-1.30M
Free Cash Flow	-88.88M
FCF Per Share	-$0.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,927.32%
Pretax Margin	-1,971.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.06%
Shareholder Yield	-1.06%
Earnings Yield	-31.53%
FCF Yield	-31.55%

Analyst Forecast

The average price target for AC Immune is $10.00, which is 230.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	230.03%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	101.22%
EPS Growth Forecast (5Y)	-2.81%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AC Immune has an Altman Z-Score of -4.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.33
Piotroski F-Score	1